Gene therapy progress and prospects: Nonviral vectors

Gene Therapy

Volumn 9, Issue 24, 2002, Pages 1647-1652

  Niidome, T ^a   Huang, L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cationic lipid; Cationic polymer; Gene therapy; Naked DNA; Non viral vector

Indexed keywords

DNA VACCINE; ERYTHROPOIETIN; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; LIPOSOME; MACROGOL; NAKED DNA; PLASMID DNA; POLY(METHYL METHACRYLATE); POLYGLYCOLIC ACID; POLYMER; POLYMETHACRYLIC ACID DERIVATIVE;

CELL SPECIFICITY; CONTROLLED RELEASE FORMULATION; CPG ISLAND; CYTOSOL; ELECTROPORATION; ENDOSOME; ENVIRONMENTAL CHANGE; GENE CONSTRUCT; GENE EXPRESSION; GENE GUN; GENE REPLICATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HYDRODYNAMICS; IMMUNE RESPONSE; NONVIRAL GENE DELIVERY SYSTEM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; TARGET CELL; ULTRASOUND;

DNA; DNA REPLICATION; DRUG CARRIERS; ELECTROPORATION; GENE EXPRESSION; GENE THERAPY; HUMANS; LIPOSOMES; POLYMERS; TRANSFECTION;

EID: 0036954247     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301923     Document Type: Review

References (70)

1. Nishikawa M, Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 2001; 12: 861-870.
2. Li S, Ma Z. Nonviral gene therapy. Curr Gene Ther 2001; 1: 201-226.
3. Somiari S et al. Theory and in vivo application of electroporative gene delivery. Mol Ther 2000; 2: 178-187.
4. Drabick JJ et al. Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther 2001; 3: 249-255.
5. Maruyama H et al. Skin-targeted gene transfer using in vivo electroporation. Gene Ther 2001; 8: 1808-1812.
6. Dujardin N, Van Der Smissen P, Preat V. Topical gene transfer into rat skin using electroporation. Pharm Res 2001; 18: 61-66.
7. Chesnoy S, Huang L. Enhanced cutaneous gene delivery following intradermal injection of naked DNA in a high ionic strength solution. Mol Ther 2002; 5: 57-62.
8. Widera G et al. DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 2000; 164: 4635-4640.
9. Hanna E et al. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site. Cancer Gene Ther 2001; 8: 151-157.
10. Li S et al. Intramuscular electroporation delivery of IFN-α gene therapy for inhibition of tumor growth located at a distant site. Gene Ther 2001; 8: 400-407.
11. Tamura T et al. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer. Hum Gene Ther. 2001; 12: 1265-1276.
12. Liu F, Huang L. A syringe electrode device for simultaneous injection of DNA and electrotransfer. Mol Ther 2002; 5: 323-328.
13. Heller L et al. Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo. Gene Ther 2000; 7: 826-829.
14. Liu F, Hunag L. Electric gene transfer to the liver following systemic administration of plasmid DNA. Gene Ther. 1998; 8: 1531-1537.
15. Lin MT, Pulkkinen L, Uitto J, Yoon K. The gene gun: current application in cutaneous gene therapy. Int J Dermatol 2000; 39: 161-170.
16. Davidson JM, Krieg T, Eming SA. Particle-mediated gene therapy of wounds. Wound Repair Regen 2000; 8: 452-459.
17. Muangmoonchai R et al. Transfection of liver in vivo by biolistic particle delivery: its use in the investigation of cytochrome P450 gene regulation. Mol Biotechnol 2002; 20: 145-151.
18. Kuriyama S et al. Particle-mediated gene transfer into murine livers using a newly developed gene gun. Gene Ther 2000; 7: 1132-1136.
19. Yoshida S et al. Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite. Biochem Biophys Res Commun 2000; 271: 107-115.
20. Newman CM, Lawrie A, Brisken AF, Cumberland DC. Ultrasound gene therapy: on the road from concept to reality. Echocardiography 2001; 18: 339-347.
21. Amabile PG et al. High-efficiency endovascular gene delivery via therapeutic ultrasound. J Am Coll Cardiol 2001; 37: 1975-1980.
22. Taniyama Y et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105: 1233-1239.
23. Teupe C et al. Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (S1177D) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity. Circulation 2002; 105: 1104-1109.
24. Unger EC, Hersh E, Vannan M, McCreery T. Gene delivery using ultrasound contrast agents. Echocardiography 2001; 18: 355-361.
25. Lawrie A et al. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 2000; 7: 2023-2027.
26. Song J et al. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J Am Coll Cardiol 2002; 39: 726-731.
27. Shohet RV et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000; 101: 2554-2556.
28. Endoh M et al. Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol Ther 2002; 5; 501-508.
29. Budker V et al. Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J Gene Med 2000; 2: 76-88.
30. Siess DC et al. A human gene coding for a membrane-associated nucleic acid-binding protein. J Biol Chem 2000; 275: 33655-33662.
31. Liu F, Huang L. Noninvasive gene delivery to the liver by mechanical massage. Hepatology 2002; 35: 1314-1319.
32. Zhang G et al. Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates. Hum Gene Ther 2001; 12: 427-438.
33. Liu F, Huang L. Improving plasmid DNA-mediated liver gene transfer by prolonging its retention in the hepatic vasculature. J Gene Med 2001; 3: 569-576.
34. Liu F, Nishikawa M, Clemens PR, Huang L. Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA. Mol Ther 2001; 4: 45-51.
35. Dauty E, Remy JS, Blessing T, Behr JP. Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture. J Am Chem Soc 2001; 123: 9227-9234.
36. McKenzie DL, Kwok KY, Rice KG. A potent new class of reductively activated peptide gene delivery agents. J Biol Chem 2000; 275: 9970-9977.
37. Park Y, Kwok KY, Boukarim C, Rice KG. Synthesis of sulfhydryl cross-linking poly(ethylene glycol)-peptides and glycopeptides as carriers for gene delivery. Bioconjug Chem 2002; 13: 232-239.
38. Wightman L et al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med 2001; 3: 362-372.
39. Lim YB et al. Biodegradable polyester, poly[α-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier. Pharm Res 2000; 17: 811-816.
40. Koh JJ et al. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice. Gene Ther 2000; 7: 2099-2104.
41. Maheshwari A et al. Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment. Mol Ther 2000; 2: 121-130.
42. Ahn CH, Chae SY, Bae YH, Kim SW. Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release 2002; 80:273-282.
43. Wang J, Mao HQ, Leong KW. A novel biodegradable gene carrier based on polyphosphoester. J Am Chem Soc 2001; 123: 9480-9581.
44. Kurisawa M, Yokoyama M, Okano T. Gene expression control by temperature with thermo-responsive polymeric gene carriers. J Control Release 2000; 69: 127-137.
45. Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002; 54: 37-51.
46. Jeong B, Bae YH, Kim SW. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. J Control Release 2000; 63: 155-163.
47. Harada-Shiba M et al. Polyion complex micelles as vectors in gene therapy - pharmacokinetics and in vivo gene transfer. Gene Ther 2002; 9: 407-414.
48. Turk MJ, Reddy JA, Chmielewski JA, Low PS. Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs. Biochim Biophys Acta 2002; 1559: 56-68.
49. Lee H, Jeong JH, Park TG. A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. J Control Release 2001; 76: 183-192.
50. Rittner K et al. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol Ther 2002; 5: 104-114.
51. Bremner KH, Seymour LW, Pouton CW. Harnessing nuclear localization pathways for transgene delivery. Curr Opin Mol Ther 2001; 3: 170-177.
52. Tachibana R, Harashima H, Shinohara Y, Kiwada H. Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors. Adv Drug Deliv Rev 2001; 52: 219-226.
53. Cartier R, Reszka R. Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems. Gene Ther 2002; 9: 157-167.
54. Tousignant JD et al. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice. Hum Gene Ther 2000; 11: 2493-2513.
55. Yew NS et al. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol Ther 2000; 1: 255-262.
56. Hofman CR et al. Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activity. Gene Ther 2001; 8: 71-74.
57. Li S et al. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol 2000; 278L: 504-511.
58. Tan Y et al. Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mol Ther 2001; 3: 673-682.
59. Miao CH et al. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Mol Ther 2000; 1: 522-532.
60. Chen ZY et al. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol Ther 2001; 3: 403-410.
61. Maruyama-Tabata H et al. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer. Gene Ther 2000; 7: 53-60.
62. Tomiyasu K et al. Direct intra-cardiomuscular transfer of beta2-adrenergic receptor gene augments cardiac output in cardiomyopathic hamsters. Gene Ther 2000; 7: 2087-2093.
63. Cui FD et al. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors. Gene Ther 2001; 8: 1508-1513.
64. Stoll SM et al. Epstein-Barr virus/human vector provides high-level, long-term expression of α1-antitrypsin in mice. Mol Ther 2001; 4: 122-129.
65. Ivics Z, Hackett PB, Plasterk RH, Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997; 91: 501-510.
66. Yant SR et al. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 2000; 25: 35-41.
67. Thyagarajan B et al. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 2001; 21: 3926-3934.
68. Olivares EC, Hollis RP, Calos MP. Phage R4 integrase mediates site-specific integration in human cells. Gene 2001; 278: 167-176.
69. Sclimenti CR, Thyagarajan B, Calos MP. Directed evolution of a recombinase for improved genomic integration at a native human sequence. Nucleic Acids Res 2001; 29: 5044-5051.
70. Stoll SM, Ginsburg DS, Calos MP. Phage TP901-1 site-specific integrase functions in human cells. J Bacteriol 2002; 184: 3657-3663.